Thus, dronedarone appears safe for patients with a history of mild-to-moderate heart failure, but not in those with similar clinical characteristics to patients enrolled in the ANDROMEDA trial.

Amiodarone effectively maintains sinus rhythm in patients with atrial fibrillation, and although dronedarone is less effective it has a better safety profile. The choice of antiarrhythmic drug (or ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...